ARCA biopharma Inc. | Ownership
Companies that own ARCA biopharma Inc.
Tekla Capital Management LLC
811,227
5.83%
0
0.02%
06/30/2018
Renaissance Technologies LLC
419,250
3.01%
-114,163
0%
06/30/2018
Acadian Asset Management LLC
100,336
0.72%
0
0%
06/30/2018
Aveo Capital Partners LLC
93,258
0.67%
0
0.03%
06/30/2018
PanAgora Asset Management, Inc.
88,995
0.64%
1
0%
06/30/2018
Geode Capital Management LLC
48,679
0.35%
48,679
0%
06/30/2018
G1 Execution Services LLC
47,636
0.34%
47,636
0%
06/30/2018
Medical Strategy GmbH
41,500
0.3%
0
0.01%
11/30/2017
The Vanguard Group, Inc.
40,180
0.28%
4,000
0%
06/30/2018
Virtu Financial BD LLC
34,128
0.25%
-33,872
0%
06/30/2018
| Address |
11080 CirclePoint Road
Westminster Colorado 80020
United States
|
|
Employees
|
- |
| Website |
http://www.arcabiopharma.com |
| Updated |
07/08/2019 |
| ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. |
